Prozac recall controversy gets interesting

The prozac recall controvery keeps getting interesting. After the Britis Medical Journal claimed that they had incriminating documents against Eli Lilly showing that the company might have known for more than a decade that Prozac was a dangerous drug, the company is now saying that these are not new documents and have been in the public domain for a while.

So who is telling the truth? No word yet from the FDA which is apparently reviewing the documents. If the FDA behaves the way it handled Vioxx recall, then Americans do not have much hope from the agency.